James Hussey

Biography

James M. (“Jim”) Hussey has been a President or CEO of various health care and advanced technology related companies over the past +20 years. After graduating from Pharmacy School at Butler University in 1982 and getting his MBA from University of Illinois – Chicago in 1984, Jim joined Bristol Myers Squibb, a global pharmaceutical company. During his 11 years at BMS, Jim held positions of increasing responsibility within the US business reaching the position of General Manager – US in 1992. He left BMS in 1994 to start the first of his many start-up ventures. Over the next 20 years, Jim served as CEO, President or Founder at Physicians Quality Care, NeoPharm Pharmaceuticals (NEOL: NASDAQ), NanoInk, Inc., Sagent Pharmaceuticals (SGNT: NASDAQ) and now Athenex Pharmaceutical Division, a global pharmaceutical company. He also served on the leadership team at Ovation Pharmaceuticals. Jim has served on many different Board of Directors both as CEO/President or as an Independent Director. Jim served on the board of Option Care, a public (OPTN: NASDAQ) specialty pharmacy business. He has been an angel investor for biotech and served as an advisor to many biotech and health care startups. Jim has served on government boards and on the boards of charitable organizations. Jim currently is Chairman of the Board at Symbria, a National Long Term Care Health Care Service Provider based in Chicago. He serves as Independent Director on the Power Wellness Board, a Global Wellness Center Management Company and on the Board of Vidasym, a biotech startup. Jim serves as a Consultant to the health care, biotech, nanotech, compound pharmacy and branded and generic pharmaceutical industries in addition to his role as Executive Vice President at Athenex Pharmaceutical Division.

Research Interest

 Cancer